Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BioLineRx
Israeli grant of $21M awarded for development preclinical drug candidates
January 9th, 2005
The Israeli Office of the Chief Scientist announced the selection of BioLineRx as the sole recipient of a $21 million grant for the development of preclinical compounds as part of a special initiative for the advancement of the Israeli Biotech industry. The initiative, launched by the Israeli Ministry of Industry, Trade and Labor, is designed to encourage the further development of innovative projects from Israeli universities, hospitals, research centers and early stage companies. According to BioLineRx's CEO, Morris Laster, "BioLineRx's award of this new national status not only provides significant funding for development of additional preclinical...
Source: Aging & Elder Health Week (2005-01-09)
|
